Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M Bailey

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Oncogene|August 18, 2019
MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor typesJ Randall McAuley, Kelly M Bailey, Prasanna Ekambaram, et al.
Cancer Research Communications|August 26, 2025
TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing SarcomaJessica D Daley, Elina Mukherjee, David Ferraro, et al.
Pediatric Blood & Cancer|August 29, 2025
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor CommitteeJessica D Daley, Susan L Whiteway, Christine M Heske, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Cell Reports|September 30, 2016
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD CleavageLinda R Klei, Dong Hu, Robert Panek, et al.
Cancers|September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy BreakoutJacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
Molecular Cancer Therapeutics|September 5, 2025
Advancing preclinical biology for Ewing Sarcoma: an international effortFilemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 27, 2024
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus StatementMatthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Oncogene|August 18, 2019
MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor typesJ Randall McAuley, Kelly M Bailey, Prasanna Ekambaram, et al.
Cancer Research Communications|August 26, 2025
TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing SarcomaJessica D Daley, Elina Mukherjee, David Ferraro, et al.
Pediatric Blood & Cancer|August 29, 2025
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor CommitteeJessica D Daley, Susan L Whiteway, Christine M Heske, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Cell Reports|September 30, 2016
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD CleavageLinda R Klei, Dong Hu, Robert Panek, et al.
Cancers|September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy BreakoutJacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
Molecular Cancer Therapeutics|September 5, 2025
Advancing preclinical biology for Ewing Sarcoma: an international effortFilemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 27, 2024
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus StatementMatthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, et al.
Pageof 4